It is widely acknowledged that autophagy plays a role in immunity, and autophagy has lately been involved in cancer immunotherapy.[50] Since cancer cells can evade immune detection by inhibiting autophagy, autophagy boosters may improve the efficacy of cancer immunotherapy.[51] In this study, we observed a positive correlation between SAT1 and PD1 as well as PD‐L1, which hinted that TNBC patients with high SAT1 expression may respond better to immunotherapy. The gene discussed is CD274; the disease is cancer.